INTRODUCTIONAltered maternal lipid metabolism is common in pregnancy. In women with GDM physiological changes in insulin and lipid levels are exaggerated during pregnancy, leading to significant alterations in lipid levels compared to normal pregnancy. Gestational diabetes mellitus (GDM), defined as glucose intolerance first diagnosed during pregnancy, is increasing in prevalence worldwide.1 Up to 22% of all pregnancies are affected by GDM, and this prevalence may be higher under new diagnostic criteria.2 Physiological insulin resistance underlies all pregnancies beginning around 24-28 weeks of gestation and progressing through the third trimester. Altered maternal lipid metabolism is also common in pregnancy with modest increases in lipids early in pregnancy and significant elevations of lipids later in pregnancy, specifically, triglycerides and to a lesser extent phospholipids and cholesterol. 3,4 In women with GDM, the physiological changes in insulin and lipids are exaggerated and may indicate underlying metabolic dysfunction that transiently manifests during pregnancy.
5ABSTRACT Background: Altered maternal lipid metabolism is common in pregnancy. In women with GDM physiological changes in insulin and lipid levels are exaggerated during pregnancy, leading to significant alterations in lipid levels compared to normal pregnancy. Assessment of raise in certain lipid parameters in pregnant women with GDM and non GDM. Methods: A hospital based case control study done in the Department of OBG AIMS Bellur, Mandya, Karnataka, with sample size of 100 pregnant women. 50 cases of GDM (confirmed by OGCT) and 50 controls (non GDM cases) pregnant women were taken during 1 year study period from June 2015 to June 2016. Mean age of presentation of women was 20-25 yrs. Ethical committee clearance was taken and consent from control and cases was taken. Fasting lipid profile was sent. Parameters obtained were analyzed using student t test for statistical significance. Results: There was no statistical difference in age and parity between control and case group. Triglyceride (cases-286.4±77.60 mg/dl) (controls-166±26mg/dl), total cholesterol (cases-256.5±41.7 mg/dl) (controls -202.5±20.18mg/dl), VLDL (cases-53.4±13.2 mg/dl) (controls-46.6±13.1mg/dl) showed statistically significant values (p value<0.001). HDL and LDL values did not show any statistical significance (p value >0.5) among GDM and non GDM group. Lipid profile was performed predominately in women in II trimester. Conclusions: Serum triglyceride, total cholesterol and VLDL level are significantly higher among woman with GDM compared to non GDM pregnant women, where in the lipid profile can be used as predictor for gestational diabetes mellitus in future which needs further research.